Cargando…
The Relationship Between Central Drusen Volume and Low-Luminance Deficit in Age-Related Macular Degeneration
PURPOSE: To determine the relationship between central drusen volume and low-luminance deficit (LLD) in visual acuity (VA) in patients with intermediate age-related macular degeneration (AMD). METHODS: In this cross-sectional study, 42 patients with intermediate AMD underwent testing for VA and low-...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401889/ https://www.ncbi.nlm.nih.gov/pubmed/32821472 http://dx.doi.org/10.1167/tvst.9.4.10 |
Sumario: | PURPOSE: To determine the relationship between central drusen volume and low-luminance deficit (LLD) in visual acuity (VA) in patients with intermediate age-related macular degeneration (AMD). METHODS: In this cross-sectional study, 42 patients with intermediate AMD underwent testing for VA and low-luminance VA (LLVA), as well as spectral-domain optical coherence tomography. LLD was calculated as the difference between VA and LLVA. Central drusen volume was measured in the central 3 mm of the macula, defined as the volume between the inner border of the retinal pigment epithelium and Bruch's membrane. RESULTS: Mean ± standard deviation (SD) LLD was 0.32 ± 0.12 logMAR and mean ± SD drusen volume was 0.18 ± 0.09 mm(3). No linear relationship was identified between central 3 mm drusen volume and LLD (P = 0.215). R(2) for the bivariate linear model was 0.038 (95% confidence interval 0–0.222). Limitation of the analysis to drusen volumes measured in the central 1 mm of the macula did not impact results (R(2) = 0.075), nor did incorporation of lens status into the model (R(2) = 0.067) or censoring of patients with nonfoveal subretinal drusenoid deposits (R(2) = 0.071). CONCLUSIONS: The amount of drusen within the central 3 mm of the macula does not appear to be related to LLD in intermediate AMD. These measures may be manifestations of different underlying pathophysiological mechanisms. TRANSLATIONAL RELEVANCE: Understanding relationships between markers for AMD progression may help guide development of improved clinical grading scales for AMD. |
---|